Gabor E. Ormos

Establishing, leading and developing North West African CHC business with full P&L ownership

Managed leader GI (Dulcolax) and Cough&Cold (Lysopaine) category P&Ls securing €35m annual sales.

Led a local major brand acquisition project. Ignited, implemented CHC France business strategy Vision 100.

Drove global GI category flagship brands Buscopan, Zantac, Gastol securing €300m annual sales

Implemented flagship brands` strategies and monitored ROIs in 12 markets

Delivered of additional revenue in excess €100m by driving two global Sensodyne NPD projects from ideation to launch in the department of Global Strategic Projects at Future Group GSK, Weybridge

Established channel, distribution and key account promotional strategy, and optimized trade spend. Captured Oral Health Care category captaincy at three key accounts (DM, AS Watson, Schlecker). Coordinated Sensodyne brand on European level.

Managed portfolio of leader household care brands` P&L. Delivered +6% market share growth in detergent category by repositioning local brand BIOPON.

Managed portfolio of leader skin and persona care brands` P&L. Maintained leader position of NIVEA Sun despite offensive investment plan of major competitor. Successfully launched sensitive skin sun care line and several NIVEA Deo line extensions.

Cooperation with Ecole Nationale Supérieure des Mines de Paris, Collège des Ingénieurs

Cooperation with Université Jean Moulin Lyon III